Gadofosveset-enhanced magnetic resonance angiography
Open Access
- 1 January 2008
- journal article
- review article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 4 (1), 1-9
- https://doi.org/10.2147/vhrm.2008.04.01.1
Abstract
Peer reviewed article authored by (Mathias Goyen). Read article or submit your manuscript for publishing.Keywords
This publication has 25 references indexed in Scilit:
- First-Pass Whole-Body Magnetic Resonance Angiography (MRA) Using the Blood-Pool Contrast Medium Gadofosveset TrisodiumInvestigative Radiology, 2007
- Nephrogenic systemic fibrosis is not exclusively associated with gadodiamideEuropean Radiology, 2007
- Initial imaging recommendations for Vasovist angiographyEuropean Radiology Supplements, 2006
- MR Angiography of Aortoiliac Occlusive Disease: A Phase III Study of the Safety and Effectiveness of the Blood-Pool Contrast Agent MS-325Radiology, 2005
- Cardiovascular Screening with Parallel Imaging Techniques and a Whole-Body MR ImagerRadiology, 2005
- Blood Pool MR Angiography of Aortic Stent-Graft EndoleakAmerican Journal of Roentgenology, 2004
- 3D pulmonary perfusion MRI and MR angiography of pulmonary embolism in pigs after a single injection of a blood pool MR contrast agentEuropean Radiology, 2004
- Performance of a new gadolinium‐based intravascular contrast agent in free‐breathing inversion‐recovery 3D coronary MRAMagnetic Resonance in Medicine, 2002
- MRA of the abdominal aorta and lower extremitiesJournal of Magnetic Resonance Imaging, 2000
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985